Biology:SANT-2
SANT-2 is a small-molecule antagonist of the sonic hedgehog (Shh) pathway,[1] a developmental signaling cascade implicated in tissue patterning, stem cell maintenance, and the progression of various cancers. By targeting the smoothened (SMO) receptor, SANT-2 disrupts aberrant Shh pathway activation, thereby inhibiting downstream transcriptional programs that drive uncontrolled cell proliferation and survival.[1] Due to its potency and specificity, SANT-2 has become a tool for studying Hedgehog-dependent oncogenesis and holds potential as a lead compound for the development of targeted anticancer therapeutics.
Pharmacology
SANT-2 is a potent antagonist of the Smoothened (SMO) receptor, a key component of the Sonic hedgehog (Shh) signaling pathway, displaying a dissociation constant (KD) of 12 nM for SMO binding. Its pharmacological profile is characterized by strong allosteric binding—similar to the first-in-class SMO antagonist SANT-1, interfering with the receptor’s activity even in the presence of endogenous and synthetic agonists. SANT-2 efficiently displaces radiolabeled SAG-1.3 and cyclopamine bound to SMO, with inhibition constants (Kd) of 7.8 nM and 8.4 nM, respectively, highlighting its high affinity and specificity for this receptor.[1][2][3]
Synthesis
SANT-2 is synthesized by coupling 2-chloro-5-nitrobenzoic acid with o-phenylenediamine to form a benzimidazole intermediate. Béchamp reduction of the nitro group affords the corresponding aniline, which is then coupled with 3,4,5-triethoxybenzoic acid via amide formation to yield SANT-2.[1]
References
- ↑ 1.0 1.1 1.2 1.3 "Synthesis and biological evaluation of SANT-2 and analogues as inhibitors of the hedgehog signaling pathway". Bioorganic & Medicinal Chemistry 17 (14): 4943–4954. July 2009. doi:10.1016/j.bmc.2009.06.008. PMID 19541490.
- ↑ "Evidence for allosteric interactions of antagonist binding to the smoothened receptor". The Journal of Pharmacology and Experimental Therapeutics 329 (3): 995–1005. June 2009. doi:10.1124/jpet.109.152090. PMID 19304771.
- ↑ "Small molecule modulation of Smoothened activity". Proceedings of the National Academy of Sciences of the United States of America 99 (22): 14071–14076. October 2002. doi:10.1073/pnas.182542899. PMID 12391318. Bibcode: 2002PNAS...9914071C.
 |  |
